TRACY CHAVEZ: Open Payments
NPI 1932229614 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 17 payments from 7 companies in 2025. Trend: 2023 $222 · 2024 $386 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $100 |
| Novo Nordisk Inc | 4 | $75 |
| Lilly USA, LLC | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Phadia US Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: TRELEGY ELLIPTA, MOUNJARO, Rybelsus, Ozempic, Kerendia, SHINGRIX, ImmunoCAP, INSPIRE.
Industry payments across CO — which companies pay providers there.
